With the permission of the Leas-Cheann Comhairle, I propose to take Questions Nos. 16, 17, 18, 19, and 20 together.
The Irish pharmaceutical industry produces a wide range of tablets which comply with the standards laid down in the British Pharmacopoeia, the British Pharmaceutical Codex and the British Veterinary Codex, and the recent duty was imposed to assist the development of the industry. In accordance with established practice there were no consultations regarding the duty with third parties prior to its imposition.
There has been considerable misunderstanding in certain quarters about the effect which the imposition of the duty may have on the prices of tablets to the public and some misinformed statements have appeared in the public Press on this subject. Before the duty was imposed, an undertaking was given that the Irish made tablets would be sold to the pharmaceutical trade at prices corresponding to those at which similar tablets are sold to the pharmaceutical trade in Great Britain by British pharmaceutical manufacturers. There is, therefore, no reason of which I am aware why prices to the Irish public should be higher than in Britain. In some cases external firms may have been "dumping" tablets on the Irish market at prices lower than those charged on the British market; the effect of the duty in such cases would be to protect the Irish industry against such unfair competition.
The Order provides that the duty will not be charged on tablets comprised in an importation of not more than 100 tablets. The Order also contains a licensing provision which will ensure that tablets not produced here may be imported free of the duty. In the period immediately following the imposition of the duty a very liberal attitude was adopted towards the granting of applications for licences in order that there would be no dislocation of supplies and joint discussions have taken place with representatives of the Irish pharmaceutical industry and of importing interests with a view to working out a licensing procedure which will be satisfactory to all the parties concerned. In view of the fact that supplies of such tablets as are not manufactured here will continue to be freely available there is no reason why the price of such tablets should be increased.